Introduction

Business Development & Licensing

Tillotts Pharma AG promotes its in-house developed products, Asacol^® and Colpermin^®, through its affiliates and a network of carefully selected distributors and licensees in over 55 countries with a focus on Europe and the Middle East.

More than half of Tillotts’ Asacol^® turnover in 2010 was generated by its affiliates in the Baltics, Czech Republic, Denmark, Finland, Iceland, Ireland, Norway, Sweden, the UK and through its parent company Zeria Pharmaceutical Co. Ltd in Japan.

We continue to proactively seek new partnerships in the gastrointestinal field and we invite our potential partners to explore the opportunities we can offer.

Tillotts Pharma is a proud member and sponsor of the Swiss Pharma Licensing Group.